Global Polio Vaccines Market 2018-2022

The global polio vaccines market is predicted to reach a size of about USD 2.9 billion by 2022 supported by increased funding for the development of various types of polio vaccine across the globe. Wondering how to make the most of this booming polio vaccines industry? Technavio’s extensive industry research report offers a detailed insight that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the global polio vaccines market. It also examines the competitive landscape and some polio vaccine manufacturers that include Astellas Pharma, GlaxoSmithKline, Sanofi.

Want to get a preview of how you can gain compelling insights from Technavio’s market research report? Check out the latest facts about the polio vaccine industry

The global polio vaccines market is expected to grow at a CAGR of nearly 18% during the forecast period

Polio vaccines industry growth is expected to accelerate over the next five years, driven by increase in investments for the development of different types of polio vaccine. The global polio vaccines market has witnessed significant progress over the past few years owing to the increased effort to eradicate polio across the world. According to the Global Eradication Polio Initiative, more than 16 million cases of polio have been prevented by the oral polio vaccine and eradication of polio has been achieved in most target countries. Furthermore, countries with a high risk of polio have introduced inactivated polio vaccines in their polio vaccine schedule to maintain the immunity level of polio type 2. Technavio’s polio vaccines industry analysis reveals promising markets around the world.

Want a bigger picture? Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

The Americas dominated the global polio vaccine market by geography

The largest market share in the global polio vaccines market was held by the Americas, followed by EMEA and APAC. In addition, the Americas are forecasted to continue their dominance over the next five years, while APAC will lose out a part of their market share to EMEA region. The Americas will also make the largest contribution of over 57% to the incremental growth of the market during the forecast period owing to factors such as immunization drives by government bodies, increased funding for polio vaccine supply, and innovative delivery systems. However, EMEA will display the fastest rate of growth compared to the Americas and APAC.

Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Start your 14-day FREE trial

Astellas Pharma, GlaxoSmithKline, Sanofi are among the leading polio vaccine manufacturers

The global polio vaccines market is forecasted to grow reasonably fragmented with the existence of many international and regional polio vaccine manufacturers who offer two types of polio vaccines such as OPV and IPV. The global polio vaccines market is expected to witness a significant reduction in funding for surveillance activities, increased ability to respond to disease outbreaks, and additional immunization programs in the future. Many international and regional vendors are vying for their share of the polio vaccines market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

• Astellas Pharma
• GlaxoSmithKline
• Sanofi
• Serum Institute of India

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch